(Q45990981)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

1 reference

Theodosios D. Filippatos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Michael S Kostapanos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Moses Elisaf

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

2

Haralampos J Milionis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

5

Eleni T Bairaktari

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Alexandros D Tselepis

6

object named as

Alexandros D Tselepis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Leonidas G Christogiannis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

1 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cardiovascular Pharmacology and Therapeutics

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

5-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

HDL cholesterol: physiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Antiatherogenic small, dense HDL--guardian angel of the arterial wall?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Paraoxonase and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

An overview of the extra-lipid effects of rosuvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Dose-dependent effect of rosuvastatin treatment on urinary protein excretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Change in alpha1 HDL concentration predicts progression in coronary artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

Modulation of paraoxonase (PON1) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248408331031

21 January 2018

Identifiers

DOI

10.1177/1074248408331031

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19246334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference